About Fluent BioSciences
Fluent BioSciences is a company based in Watertown (United States) founded in 2018 by Sepehr Kiani, Bill Hyun, Adam Abate, and Gary Zweiger was acquired by Illumina in July 2024. Fluent BioSciences has raised $19 million across 2 funding rounds from investors including Illumina, NIH SBIR/STTR and Illumina Ventures. Fluent BioSciences offers products and services including PIPseeker Software and User Guide. Fluent BioSciences operates in a competitive market with competitors including GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others.
- Headquarter Watertown, United States
- Founders Sepehr Kiani, Bill Hyun, Adam Abate, Gary Zweiger
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fluent BioSciences
Fluent BioSciences offers a comprehensive portfolio of products and services, including PIPseeker Software and User Guide.
Analyzes single cell RNA sequencing data and generates metrics.
Provides instructions for using PIPseeker software effectively.
People of Fluent BioSciences
Unlock access to complete
Unlock access to complete
Funding Insights of Fluent BioSciences
Fluent BioSciences has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.7 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $1.7M
-
First Round
First Round
(01 Jun 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Grant - Fluent BioSciences | Valuation |
investors |
|
| Jun, 2020 | Amount | Series A - Fluent BioSciences | Valuation | Illumina Ventures , Samsara BioCapital |
Investors in Fluent BioSciences
Fluent BioSciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, NIH SBIR/STTR and Illumina Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fluent BioSciences
Financial Statements - Fluent BioSciences
Fluent Biosciences Comparisons
Competitors of Fluent BioSciences
Fluent BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
Latest news on Fluent Biosciences
Frequently Asked Questions about Fluent BioSciences
Fluent BioSciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Fluent BioSciences is headquartered in Watertown, United States.
Sepehr Kiani is the current CEO of Fluent BioSciences. They have also founded this company.
Fluent BioSciences is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Jun 01, 2020.
Fluent BioSciences was founded in 2018 and is headquartered in Watertown, United States. Operations focus on the biotechnology sector, where a proprietary reagent known as Pre-templated Instant Partitions (PIPs) is developed. This reagent facilitates the self-assembly of individual cells or molecules into uniform partitions for nucleic acid preparation. Applications include DNA and RNA sequencing as well as single-cell molecular analysis.
Fluent BioSciences's top competitors include Neogen, Sino Biological and Qiagen.
Fluent BioSciences offers PIPseeker Software and User Guide.
Fluent BioSciences has 7 investors. Key investors include Illumina, NIH SBIR/STTR, Illumina Ventures, Samsara BioCapital, and Co-win Ventures.